[Initial experiences with clinical use of botulinum toxin type B].

Author: BeneckeR, DresslerD

Paper Details 
Original Abstract of the Article :
Recently, botulinum toxin type B (BT-B) was introduced for treatment of cervical dystonia (CD). We wish to report on experience with BT-B derived from registration studies and from our own preliminary clinical experience. Botulinum toxin type B can be used successfully in CD patients with antibody-i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00115-001-1239-2

データ提供:米国国立医学図書館(NLM)

Botulinum Toxin Type B: A New Therapeutic Option for Cervical Dystonia

Cervical dystonia, a neurological condition causing involuntary muscle contractions in the neck, can significantly impact a person's quality of life. This study explores the efficacy and safety of [botulinum toxin type B (BT-B)] in treating cervical dystonia. The researchers investigated the use of BT-B in patients with [antibody-induced failure to botulinum toxin type A therapy] and [de novo patients] (those not previously treated with botulinum toxin). The study found that BT-B was effective in reducing [dystonia symptoms] in both groups, demonstrating its potential as an alternative therapy for patients who have developed antibodies to BT-A. The study also highlights the [potential side effects] of BT-B, emphasizing the need for careful patient selection and monitoring.

A New Weapon in the Fight Against Cervical Dystonia: Botulinum Toxin Type B

The results of this study offer a promising new therapeutic option for patients with cervical dystonia. The study demonstrates the effectiveness of BT-B in reducing symptoms and suggests its potential as an alternative for patients with BT-A resistance. However, the study also underscores the need for careful consideration of potential side effects.

Navigating Treatment Options: Choosing the Right Botulinum Toxin

This study emphasizes the importance of [individualized treatment] in managing cervical dystonia. Healthcare professionals should carefully consider the patient's history, potential risks, and desired outcomes when selecting between BT-A and BT-B.

Dr. Camel's Conclusion

Just as a camel navigates a challenging desert landscape, finding the most suitable path for each terrain, patients with cervical dystonia may require different approaches to manage their condition. This study sheds light on the potential of BT-B as a valuable therapeutic option, particularly for those who have developed resistance to BT-A. By embracing a patient-centered approach and carefully considering the potential benefits and risks of each treatment option, we can empower patients to find relief and improve their quality of life.

Date :
  1. Date Completed 2002-08-16
  2. Date Revised 2019-10-25
Further Info :

Pubmed ID

11975099

DOI: Digital Object Identifier

10.1007/s00115-001-1239-2

Related Literature

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.